We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+12.37%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.31B
AUM Growth
-$8.31M
Cap. Flow
-$167M
Cap. Flow %
-12.7%
Top 10 Hldgs %
42.17%
Holding
161
New
18
Increased
32
Reduced
41
Closed
18

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$11.9M
2
PDD icon
Pinduoduo
PDD
+$10.9M
3
BBIO icon
BridgeBio Pharma
BBIO
+$9.19M
4
ITOS
iTeos Therapeutics
ITOS
+$6.95M
5
NE icon
Noble Corp
NE
+$6.73M

Top Sells

Rank Stock Value
1
SN icon
SharkNinja
SN
+$36.5M
2
BWA icon
BorgWarner
BWA
+$13.2M
3
SE icon
Sea Limited
SE
+$12.1M
4
BABA icon
Alibaba
BABA
+$9.88M
5
PTGX icon
Protagonist Therapeutics
PTGX
+$7.45M

Sector Composition

Rank Sector Weight
1 Healthcare 23.33%
2 Consumer Discretionary 14.69%
3 Financials 6.56%
4 Materials 4.95%
5 Communication Services 4.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HDSN
76
Hudson Technologies
HDSN
$260M
$2.8M 0.21%
335,790
+85,227
+34% +$705K
STGW icon
77
Stagwell
STGW
$2.21B
$2.7M 0.21%
+385,000
New +$2.64M
SVM
78
Silvercorp Metals
SVM
$2.41B
$2.62M 0.2%
+600,000
New +$2.23M
SLNO
79
DELISTED
Soleno Therapeutics
SLNO
$2.59M 0.2%
51,322
-18,678
-27% -$894K
MRNA icon
80
CALL
Moderna
MRNA
$22.5B
$2.51M 0.19%
+37,500
New +$3.44M
MDGL icon
81
PUT
Madrigal Pharmaceuticals
MDGL
$11.8B
$2.44M 0.19%
11,500
– –
GSAT icon
82
Globalstar
GSAT
$10.7B
$2.42M 0.18%
130,000
– –
GEHC icon
83
PUT
GE HealthCare
GEHC
$31.5B
$2.35M 0.18%
25,000
-25,000
-50% -$2.1M
SMRT icon
84
SmartRent
SMRT
$237M
$2.34M 0.18%
1,350,000
+242,431
+22% +$460K
AFMD
85
DELISTED
Affimed
AFMD
$2.18M 0.17%
650,000
– –
CZR icon
86
PUT
Caesars Entertainment
CZR
$6.13B
$2.09M 0.16%
50,000
-50,000
-50% -$1.88M
LKFT
87
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.71B
$2.02M 0.15%
70,000
– –
GLNG icon
88
Golar LNG
GLNG
$5.11B
$1.84M 0.14%
50,000
– –
SLV icon
89
iShares Silver Trust
SLV
$30B
$1.7M 0.13%
60,000
-30,000
-33% -$806K
GUTS icon
90
Fractyl Health
GUTS
$109M
$1.58M 0.12%
625,000
-18,000
-3% -$58.7K
PYXS icon
91
Pyxis Oncology
PYXS
$198M
$1.52M 0.12%
+414,656
New +$1.45M
CRESW
92
DELISTED
Cresud SACIF y A. Warrant
CRESW
$1.38M 0.1%
2,416,020
+43,416
+2% +$20.8K
PDLB icon
93
Ponce Financial Group
PDLB
$494M
$1.24M 0.09%
106,137
– –
RNAC icon
94
Cartesian Therapeutics
RNAC
$243M
$1.22M 0.09%
+75,431
New +$1.18M
KARO icon
95
Karooooo
KARO
$2.05B
$1.18M 0.09%
29,770
-35,321
-54% -$1.28M
IMUX icon
96
Immunic
IMUX
$191M
$1.13M 0.09%
68,465
-1,465
-2% -$20.9K
DHT icon
97
DHT Holdings
DHT
$2.9B
$1.1M 0.08%
+100,000
New +$1.1M
NGVT icon
98
Ingevity
NGVT
$2.61B
$975K 0.07%
+25,000
New +$996K
BNED icon
99
Barnes & Noble Education
BNED
$439M
$926K 0.07%
+100,000
New +$1.03M
KYNB
100
Kyntra Bio
KYNB
$28.3M
$854K 0.07%
85,536
-464
-0.5% -$7K
2 3
4
5 6

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, 683 Capital Management held 161 positions worth $1.31B, down 0.63% from $1.32B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

683 Capital Management withdrew a net $167M in Q3 2024, closing 18 positions and reducing 41 holdings. Its most notable exit was Sea Limited, an estimated $12.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, 683 Capital Management opened a new position in Pinduoduo worth $12M.

  • 683 Capital Management's largest Q3 2024 buy was Pinduoduo: 89,000 shares worth $12M.
  • 683 Capital Management added most to Baidu in Q3 2024, an estimated $11.9M increase.
  • 683 Capital Management's biggest Q3 2024 reduction was SharkNinja, cutting an estimated $36.5M.
  • 683 Capital Management fully exited Sea Limited in Q3 2024, selling an estimated $12.1M.
  • 683 Capital Management's ten largest holdings make up 42% of its $1.31B portfolio in Q3 2024.
  • 683 Capital Management opened 18 new positions and closed 18 in Q3 2024.
  • 683 Capital Management's portfolio value fell 0.63% quarter-over-quarter to $1.31B.

Based on 683 Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.